Hostname: page-component-5f56664f6-ldbxw Total loading time: 0 Render date: 2025-05-07T12:16:38.089Z Has data issue: false hasContentIssue false
  • English
  • Français

Quality of life, anxiety, depression, and distress in patients with advanced and metastatic lung cancer

Published online by Cambridge University Press:  10 October 2022

Ana Gonzalez-Ling Open the ORCID record for Ana Gonzalez-Ling [Opens in a new window] ,
Oscar Galindo Vázquez ,
Marcos Espinoza Bello ,
Rebeca Robles ,
María Luisa Rascón-Gasca ,
Luis Lara-Mejía ,
David Heredia  and
Oscar Arrieta Open the ORCID record for Oscar Arrieta [Opens in a new window]
Ana Gonzalez-Ling
Affiliation:
Servicio de Psicooncología, Instituto Nacional de Cancerología, Mexico City, Mexico
Oscar Galindo Vázquez
Affiliation:
Unidad para la Investigación y Desarrollo de la Psicooncología, Instituto Nacional de Cancerología, Mexico City, Mexico
Marcos Espinoza Bello
Affiliation:
Servicio de Psicooncología, Instituto Nacional de Cancerología, Mexico City, Mexico
Rebeca Robles
Affiliation:
Centro de Investigación en Salud Mental Global, Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz, Mexico City, Mexico
María Luisa Rascón-Gasca
Affiliation:
Dirección de Investigaciones Epidemiológicas y Psicosociales, Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz, Mexico City, Mexico
Luis Lara-Mejía
Affiliation:
Department of Thoracic Oncology, Thoracic Oncology Unit, Instituto Nacional de Cancerología, Mexico City, Mexico
David Heredia
Affiliation:
Department of Thoracic Oncology, Thoracic Oncology Unit, Instituto Nacional de Cancerología, Mexico City, Mexico
Oscar Arrieta*
Affiliation:
Department of Thoracic Oncology, Thoracic Oncology Unit, Instituto Nacional de Cancerología, Mexico City, Mexico
*
Author for correspondence: Oscar Arrieta, Head of Thoracic Oncology Unit, Instituto Nacional de Cancerología (INCan), Av. San Fernando #22, Sección XVI, Tlalpan. México City, CDMX 14080, Mexico. E-mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

Objective

Lung cancer (LC) patients have shown a predisposition for developing emotional and physical symptoms, with detrimental effects on the quality of life (QoL). This study evaluates the bidirectional relationship between main psychological disorders and clinical/sociodemographic factors with the QoL.

Methods

In this observational cross-sectional study, patients with a confirmed LC diagnosis from February 2015 to March 2018 were eligible for this study. Each participant completed screening instruments of anxiety, depression, distress, and QoL assessment. Other relevant clinical data were extracted from electronic health records. Then comparisons, correlations, and logistic regression analyses were performed.

Results

Two hundred and four cases were eligible; of them, the median age was 61 (24–84) years, most had clinical stage IV (95%), and most were under first-line therapy (53%). Concerning psychological status, 46% had symptoms of emotional distress, 35% anxiety, and 31% depression. Patients with psychological disorders experienced a worse global QoL than those without psychological impairment (p < 0.001). Increased financial issues and physical symptoms, combined with lower functioning, were also significantly associated with anxiety, depression, and distress. In the multivariate analysis, female sex and emotional distress were positively associated with an increased risk of depression; likewise, female sex, low social functioning, insomnia, and emotional distress were associated with anxiety.

Conclusions

Emotional symptoms and QoL had a significant bidirectional effect on this study; this underscores the necessity to identify and treat anxiety, depression, and distress to improve psychological well-being and the QoL in LC patients.

Keywords

Advanced lung cancerMood disordersNon-small cell lung cancerPsychiatric disordersQuality of life
Type
Original Article
Information
Palliative & Supportive Care , Volume 21 , Issue 4 , August 2023 , pp. 608 - 615
Check for updates
Copyright
Copyright © The Author(s), 2022. Published by Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

References

REFERENCES

Akechi, T, Okamura, H, Nishiwaki, Y, et al. (2002) Predictive factors for suicidal ideation in patients with unresectable lung carcinoma: a 6-month follow-up study. Cancer 95(5), 1085–1093. doi:10.1002/CNCR.10769.CrossRefGoogle Scholar
Arrieta, O, Cardona, AF, Bramuglia, GF, et al. (2011) Genotyping non-small cell lung cancer (NSCLC) in Latin America. Journal of Thoracic Oncology 6(11), 1955–1959. doi:10.1097/JTO.0B013E31822F655F.CrossRefGoogle ScholarPubMed
Arrieta, Ó, Núñez-Valencia, C, Reynoso-Erazo, L, et al. (2012) Health-Related quality of life in patients with lung cancer: Validation of the Mexican-Spanish version and association with prognosis of the EORTC QLQ-LC13 questionnaire. Lung Cancer 77(1), 205–211. doi:10.1016/J.LUNGCAN.2012.02.005.CrossRefGoogle ScholarPubMed
Arrieta, O, Angulo, LP, Núñez-Valencia, C, et al. (2013) Association of depression and anxiety on quality of life, treatment adherence, and prognosis in patients with advanced non-small cell lung cancer. Annals of Surgical Oncology 20(6), 1941–1948. doi:10.1245/S10434-012-2793-5.CrossRefGoogle ScholarPubMed
Arrieta, O, Cardona, AF, Martín, C, et al. (2015a) Updated frequency of EGFR and KRAS mutations in non-small-cell lung cancer in Latin America: The Latin-American consortium for the investigation of lung cancer (CLICap). Journal of Thoracic Oncology 10(5), 838–843. doi:10.1097/JTO.0000000000000481.CrossRefGoogle Scholar
Arrieta, O, Ramírez-Tirado, LA, Báez-Saldaña, R, et al. (2015b) Different mutation profiles and clinical characteristics among hispanic patients with non-small cell lung cancer could explain the ‘hispanic paradox’. Lung Cancer 90(2), 161–166. doi:10.1016/J.LUNGCAN.2015.08.010.CrossRefGoogle ScholarPubMed
Aukst Margetić, B, Kukulj, S, Šantić, Ž, et al. (2013) Predicting depression with temperament and character in lung cancer patients. European Journal of Cancer Care 22(6), 807–814. doi:10.1111/ECC.12080.CrossRefGoogle ScholarPubMed
Brown, CG, Brodsky, J and Cataldo, JK (2014) Lung cancer stigma, anxiety, depression and quality of life. Journal of Psychosocial Oncology 32(1), 59. doi:10.1080/07347332.2013.855963.CrossRefGoogle Scholar
Carlson, LE, Angen, M, Cullum, J, et al. (2004) High levels of untreated distress and fatigue in cancer patients. British Journal of Cancer 90(12), 2297–2304. doi:10.1038/SJ.BJC.6601887.CrossRefGoogle ScholarPubMed
Cerezo, O, Oñate-Ocaña, LF, Arrieta-Joffe, P, et al. (2012) Validation of the Mexican-Spanish version of the EORTC QLQ-C30 and BR23 questionnaires to assess health-related quality of life in Mexican women with breast cancer. European Journal of Cancer Care (England) 21(5), 684–691. doi:10.1111/j.1365-2354.2012.01336.x.CrossRefGoogle ScholarPubMed
Colleoni, M, Mandala, M, Peruzzotti, G, et al. (2000) Depression and degree of acceptance of adjuvant cytotoxic drugs. Lancet 356(9238), 1326–1327. doi:10.1016/S0140-6736(00)02821-X.CrossRefGoogle ScholarPubMed
Damm, K, Roeske, N and Jacob, C (2013) Health-related quality of life questionnaires in lung cancer trials: A systematic literature review. Health Economics Review 3(1), 15. doi:10.1186/2191-1991-3-15..CrossRefGoogle ScholarPubMed
de Jesús Almanza-Muñoz, J, Juárez, IR and Pérez, S (2008) Translation, adaptation and validation of the distress thermometer in a sample of Mexican patients. Revista de Sanidad Militar 62(5), 209–217.Google Scholar
Ferlay, J, Colombet, M, Soerjomataram, I, et al. (2019) Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. International Journal of Cancer 144(8), 1941–1953. doi:10.1002/IJC.31937.CrossRefGoogle ScholarPubMed
Galindo Vázquez, O, Benjet, C, Juárez García, F, et al. (2015) Propiedades psicométricas de La escala hospitalaria de ansiedad y depresión (HADS) En Una población de pacientes oncológicos mexicanos. Artículo Original Salud Mental 38(4), 253–258. doi:10.17711/SM.0185-3325.2015.035.CrossRefGoogle Scholar
Gonzalez, BD and Jacobsen, PB (2012) Depression in lung cancer patients: The role of perceived stigma. Psycho-Oncology 21(3), 239–246. doi:10.1002/PON.1882.CrossRefGoogle Scholar
Gonzalez-Ling, A, De La Torre-Vallejo, M, Luvian-Morales, J, et al. (2017) P3.05-003 anxiety and depression in patients with EGFR+ NSCLC receiving treatment with TKIs topic: Symptoms, therapeutic interventions. Journal of Thoracic Oncology 12, S1414. doi:10.1016/j.jtho.2016.11.2165.CrossRefGoogle Scholar
Meijer, A, Roseman, M, Delisle, VC, et al. (2013) Effects of screening for psychological distress on patient outcomes in cancer: A systematic review. Journal of Psychosomatic Research 75(1), 1–17. doi:10.1016/J.JPSYCHORES.2013.01.012.CrossRefGoogle ScholarPubMed
Oñate-Ocaña, LF, Alcántara-Pilar, A, Vilar-Compte, D, et al. (2009) Validation of the Mexican Spanish version of the EORTC C30 and STO22 questionnaires for the evaluation of health-related quality of life in patients with gastric cancer. Annals of Surgical Oncology 16(1), 88–95. doi:10.1245/S10434-008-0175-9.CrossRefGoogle ScholarPubMed
Ownby, KK (2019) Use of the distress thermometer in clinical practice. Journal of the Advanced Practitioner in Oncology 10(2), 175.Google ScholarPubMed
Park, KU (2008) Assessment of change of quality of life in terminally ill patients under cancer pain management using the EORTC core quality of life questionnaire (QLQ-C30) in a Korean sample. Oncology 74(Suppl1), 7–12. doi:10.1159/000143212.CrossRefGoogle Scholar
Price, A, Goodwin, L, Rayner, L, et al. (2012) Illness perceptions, adjustment to illness, and depression in a palliative care population. Journal of Pain and Symptom Management 43(5), 819–832. doi:10.1016/J.JPAINSYMMAN.2011.05.013.CrossRefGoogle Scholar
Riba, MB, Donovan, KA, Andersen, B, et al. (2019) Distress management, version 3.2019, NCCN clinical practice guidelines in oncology. Journal of the National Comprehensive Cancer Network: JNCCN 17(10), 1229–1249. doi:10.6004/JNCCN.2019.0048.CrossRefGoogle ScholarPubMed
Salminen, EK, Silvoniemi, M, Syrjänen, K, et al. (2013) Opioids in pain management of mesothelioma and lung cancer patients. Acta Oncologica 52(1), 30–37. doi:10.3109/0284186X.2012.725944.CrossRefGoogle ScholarPubMed
Saunders, J, Ashton, M, Hall, C, et al. (2019) Pain management in patients with malignant mesothelioma: Challenges and solutions. Lung Cancer 10, 37–46. doi:10.2147/LCTT.S192558.Google ScholarPubMed
Schellekens, MPJ, van den Hurk, DGM, Prins, JB, et al. (2016) The suitability of the hospital anxiety and depression scale, distress thermometer and other instruments to screen for psychiatric disorders in both lung cancer patients and their partners. Journal of Affective Disorders 203, 176–183. doi:10.1016/J.JAD.2016.05.044.CrossRefGoogle ScholarPubMed
Shen, MJ, Coups, EJ, Li, Y, et al. (2015) The role of posttraumatic growth and timing of quitting smoking as moderators of the relationship between stigma and psychological distress among lung cancer survivors who are former smokers. Psycho-Oncology 24(6), 683–690. doi:10.1002/PON.3711.CrossRefGoogle ScholarPubMed
Siegel, RL, Miller, KD and Jemal, A (2020) Cancer statistics, 2020. CA: A Cancer Journal for Clinicians 70(1), 7–30. doi:10.3322/CAAC.21590.Google ScholarPubMed
Uchitomi, Y, Mikami, I, Nagai, K, et al. (2003) Depression and psychological distress in patients during the year after curative resection of non-small-cell lung cancer. Journal of Clinical Oncology 21(1), 69–77. doi:10.1200/JCO.2003.12.139.CrossRefGoogle ScholarPubMed
Ugalde, A, Aranda, S, Krishnasamy, M, et al. (2012) Unmet needs and distress in people with inoperable lung cancer at the commencement of treatment. Support Care Cancer 20(2), 419–423. doi:10.1007/s00520-011-1296-4.CrossRefGoogle ScholarPubMed
Walker, J, Hansen, CH, Martin, P, et al. (2014a) Prevalence, associations, and adequacy of treatment of major depression in patients with cancer: A cross-sectional analysis of routinely collected clinical data. The Lancet Psychiatry 1(5), 343–350. doi:10.1016/S2215-0366(14)70313-X.CrossRefGoogle Scholar
Walker, J, Holm Hansen, C, Martin, P, et al. (2014b) Prevalence, associations, and adequacy of treatment of major depression in patients with cancer: A cross-sectional analysis of routinely collected clinical data. The Lancet Psychiatry 1(5), 343–350. doi:10.1016/S2215-0366(14)70313-X.CrossRefGoogle Scholar
Weeks, JC, Catalano, PJ, Cronin, A, et al. (2012) Patients’ expectations about effects of chemotherapy for advanced cancer from the departments of medical oncology (Abstract). New England Journal of Medicine 17, 1616–1641. doi:10.1056/NEJMoa1204410.CrossRefGoogle Scholar
Zigmond, AS and Snaith, RP (1983) The hospital anxiety and depression scale. Acta Psychiatrica Scandinavica 67(6), 361–370. doi:10.1111/J.1600-0447.1983.TB09716.X.CrossRefGoogle ScholarPubMed